How much funding has TRETHERA CORPORATION raised?

TRETHERA CORPORATION has raised $11.8M in total funding, most recently a Grant round.

When was TRETHERA CORPORATION founded?

TRETHERA CORPORATION was founded in 2022.

Where is TRETHERA CORPORATION headquartered?

TRETHERA CORPORATION is headquartered in Sherman Oaks, California, United States.

What industry is TRETHERA CORPORATION in?

TRETHERA CORPORATION operates in Biotech, Healthcare.

How many employees does TRETHERA CORPORATION have?

TRETHERA CORPORATION has 1-10 employees.

TRETHERA CORPORATION

Unmatched Expertise Driving Scientific Breakthroughs

Sherman Oaks, United States · Founded 2022 · $11.8M raised

Biotech

Healthcare

Headquarters: Sherman Oaks, California
Employees: 1–10
Founded: 2022
Business Model: B2G

Website: trethera.com
Total Funding: $11.8M
Last Round: $1.8M GrantSep 2025

About

Trethera Corporation is a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases. Their lead candidate TRE-515, a deoxycytidine kinase (dCK) inhibitor, has received FDA approval for Phase 1 trials in solid tumors and holds FDA Orphan Drug Status for two indications. Founded by UCLA scientists, Trethera is backed by NIH SBIR grants and has a clear path to commercialization.

Summary

TRETHERA CORPORATION is a Biotech company based in Sherman Oaks, United States, founded in 2022. It has raised $11.8M in total, most recently a $1.8M Grant round in Sep 2025.